Globus Medical, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Keith W. Pfeil

Globus Medical, Inc.’s own tally for this item (“Elect Director: Keith W. Pfeil”): 293,453,432 for, 28,120,775 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the director nominees listed below were elected by the Company's stockholders at the Annual Meeting to serve a three-year term on the Board.”
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 136 asset managers below reported 37,502,427 for, 8,489,364 withheld, 90 abstained, 133 not voted.

Showing the 25 largest of 136 asset managers. See all 136 in the interactive database.

Description as filed by funds: Election of two Class II directors to serve until the 2029 Annual Meeting of Stockholders: Robert Douglas

Globus Medical, Inc.’s own tally for this item (“Elect Director: Robert A. Douglas”): 311,683,904 for, 9,890,303 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Each of the director nominees listed below were elected by the Company's stockholders at the Annual Meeting to serve a three-year term on the Board.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 136 asset managers below reported 42,836,587 for, 3,155,262 withheld, 32 abstained, 133 not voted.

Showing the 25 largest of 136 asset managers. See all 136 in the interactive database.

Description as filed by funds: Approval of an amendment to the Globus Medical, Inc. 2021 Equity Incentive Plan to increase the number of authorized shares thereunder by 1,000,000.

Globus Medical, Inc.’s own tally for this item (“2. Approval of 2021 Equity Incentive Plan Amendment”): 246,228,534 for, 75,266,538 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the 2021 Equity Incentive Plan Amendment.”
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Globus Medical, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Incentive Stock Option Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “Amend Omnibus Stock Plan” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 137 asset managers below reported 8,051,311 for, 37,862,262 against, 23,014 abstained, 133 not voted.

Showing the 25 largest of 137 asset managers. See all 137 in the interactive database.

Description as filed by funds: Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote).

Globus Medical, Inc.’s own tally for this item (“4. Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers”): 316,289,675 for, 5,212,943 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on a non-binding, advisory basis the 2025 compensation of the Company's named executive officers, as described in the Proxy Statement.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 134 managers: 45,857,917 for, 109,110 against, 23,014 abstained, 133 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 467 managers: 64,987,954 for, 4,042,605 against, 369 abstained, 7,602 not voted, 1,083,696 mixed. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as the company's independent registered public accounting firm for the year ending December 31, 2026.

Globus Medical, Inc.’s own tally for this item (“3. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 327,965,803 for, 467,955 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 138 asset managers below reported 45,987,640 for, 51 against, 23,014 abstained, 133 not voted.

Showing the 25 largest of 138 asset managers. See all 138 in the interactive database.